Giuseppe Traversa

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients

Gianluca Trifirò, Marco Massari, Roberto Da et al. · Drug Safety · 2020 · 56 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +16

Off-label use of medicines in children: can available evidence avoid useless paediatric trials?

Giovanni Tafuri, Francesco Trotta, Hubert G. M. Leufkens et al. · European Journal of Clinical Pharmacology · 2008 · 50 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +15

Stevens-Johnson Syndrome Associated with Drugs and Vaccines in Children: A Case-Control Study

Umberto Raucci, Rossella Rossi, Roberto Da et al. · PLoS ONE · 2013 · 35 citations · Full text

Medicine, Child Health, Pediatrics +14

How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009–2014

Ilaria Marcianò, Ylenia Ingrasciotta, Francesco Giorgianni et al. · BioDrugs · 2016 · 35 citations

Medicine, Pharmacology, Pharmacotherapy +12

Drug use and acute leukemia

Giuseppe Traversa, Francesca Menniti‐Ippolito, Roberto Da et al. · Pharmacoepidemiology and Drug Safety · 1998 · 33 citations

Medicine, Oncology, Pharmacology +11